| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/06/1994 | CN1088836A Recombined hirudin and its compound useful for preparation of medicine for preventing and treating thrombosis |
| 07/06/1994 | CN1025350C Method for promoting formation of inner molecular disulfide bond of recombination protein in solution of denaturing agent |
| 07/05/1994 | US5326857 ABO genotyping |
| 07/05/1994 | US5326700 DNA sequences encoding t-PA derivatives with cleavable sites |
| 07/05/1994 | US5326558 Megakaryocytopoietic factor |
| 07/05/1994 | CA2112652A1 New transdominant tat variants for hiv virus |
| 07/05/1994 | CA1330545C Characteristics and use of the anti-cea antibody produced by the hybridoma having the atcc number hbl0029 |
| 07/01/1994 | EP0724633A4 Recombinant transferrins, transferrin half-molecules and mutants thereof |
| 07/01/1994 | CA2086577A1 Potential target for immunotherapy to prevent replication of hiv (aids virus) in humans: cdna and protein for a putative regulator of hiv gag polyprotein expression reconstructed from the antisense strand of human p53 gene |
| 06/30/1994 | DE4344425A1 Collecting N-terminal peptide fragments of proteins |
| 06/30/1994 | CA2112314A1 Process for production of cell cultures with elevated content of endogenous cytokines |
| 06/29/1994 | EP0603735A2 Monoclonal antibodies that define a unique antigen of human B-cell antigen receptor complex |
| 06/29/1994 | EP0603672A2 Process for the production of recombinant and synthetic peptides and their use |
| 06/29/1994 | EP0603671A2 Process of reactivating purified membrane proteins |
| 06/29/1994 | EP0603307A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
| 06/29/1994 | EP0603216A1 Biocidal proteins |
| 06/29/1994 | EP0603194A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 06/29/1994 | EP0514416B1 Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use |
| 06/29/1994 | EP0444118B1 Pyruvate-kinase-isoenzyme-type-m2 (tumour m2-pk) specific antibodies, process for producing them and use |
| 06/29/1994 | EP0406272B1 Production of insulin-like growth factor binding protein |
| 06/29/1994 | CN1025219C Monoclonal antibody specific to HTV antigens |
| 06/28/1994 | US5324715 Protein for inhibiting collagen-stimulated platelet aggregation |
| 06/28/1994 | US5324655 Human Y-interferon signal peptide-tumor necrosis factor(TNF) gene fusions |
| 06/28/1994 | US5324641 DNA sequences encoding insulin precursors and methods of production |
| 06/28/1994 | US5324640 Human B-cell differentiation factor and process of producing said factor |
| 06/28/1994 | US5324637 Adjusting magnesium concentration by addition of magnesium salt |
| 06/28/1994 | US5324630 Methods and compositions for diagnosing lyme disease |
| 06/28/1994 | US5324628 Use of chymotrypsin for the inactivation of prekallikrein activator |
| 06/28/1994 | CA1330426C Method for producing a heterologous protein in insect cells |
| 06/28/1994 | CA1330420C Compositions containing growth hormone peptide fragments |
| 06/24/1994 | CA2112193A1 Process for preparing recombinant and synthetic peptides, and their use |
| 06/24/1994 | CA2112192A1 Process for reactivating purified membrane proteins |
| 06/23/1994 | WO1994013836A1 Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies |
| 06/23/1994 | WO1994013819A1 Expression system for producing apolipoprotein ai-m |
| 06/23/1994 | WO1994013813A1 Cells with altered betaine catabolism, their preparation and their use, in particular for producing metabolites or enzymes |
| 06/23/1994 | WO1994013812A2 Novel entomopoxvirus genes, proteins and methods of use thereof |
| 06/23/1994 | WO1994013810A1 A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 06/23/1994 | WO1994013808A2 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 06/23/1994 | WO1994013807A1 Clotting inhibitor made from protostomia saliva |
| 06/23/1994 | WO1994013806A1 Multivalent single chain antibodies |
| 06/23/1994 | WO1994013805A1 Humanised antibodies directed against a33 antigen |
| 06/23/1994 | WO1994013804A1 Multivalent and multispecific binding proteins, their manufacture and use |
| 06/23/1994 | WO1994013803A1 Dna sequence encoding the cpg-1 neural polypeptide and the polypeptide encoded thereby |
| 06/23/1994 | WO1994013802A1 D4 gene and methods of use thereof |
| 06/23/1994 | WO1994013801A1 Mammalian receptors for interleukin-10 (il-10) |
| 06/23/1994 | WO1994013799A1 Stably transfected cell lines expressing gaba-a receptors |
| 06/23/1994 | WO1994013798A1 Agents for the prevention and treatment of human alzheimer's disease |
| 06/23/1994 | WO1994013795A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 06/23/1994 | WO1994013788A1 Recombinant viral vector system |
| 06/23/1994 | WO1994013787A1 Method for enhancing the differentiation of plant cells in culture |
| 06/23/1994 | WO1994013785A2 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 06/23/1994 | WO1994013701A2 Delta-like gene expressed in neuroendocrine tumors |
| 06/23/1994 | WO1994013700A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | WO1994013699A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | WO1994008023A3 Biotechnological method of producing biotin |
| 06/23/1994 | CA2151587A1 Process for promoting the differenciation of plant cells during culture |
| 06/23/1994 | CA2151455A1 Delta-like gene expressed in neuroendocrine tumors |
| 06/23/1994 | CA2151128A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2151126A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2150909A1 Clotting inhibitor made from protostomia saliva |
| 06/23/1994 | CA2150807A1 Dna sequence encoding the cpg-1 neutral polypeptide and the polypeptide encoded thereby |
| 06/23/1994 | CA2150249A1 Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/23/1994 | CA2128544A1 Humanised antibodies directed against a33 antigen |
| 06/23/1994 | CA2112046A1 Antibodies, polypeptides, production and use thereof |
| 06/23/1994 | CA2110852A1 Monoclonal antibodies that define a unique antigen of human b cell receptor complex and methods of using same for diagnosis and treatment |
| 06/22/1994 | EP0603128A1 Process for the production of polypeptides |
| 06/22/1994 | EP0603031A2 Antiviral antibiotic BU-4724V and preparation thereof |
| 06/22/1994 | EP0602899A2 Modified proteins containing controllable intervening sequences and methods of their production |
| 06/22/1994 | EP0602688A1 Methionine free G-CSf from prokaryotes |
| 06/22/1994 | EP0602601A2 Stable antibody solution and stabilization of antibody |
| 06/22/1994 | EP0602248A1 Monoclonal antibody against human lung surfactant apoprotein d and use thereof |
| 06/22/1994 | EP0602193A1 Enhanced expression in plants |
| 06/22/1994 | EP0602189A1 Nucleic sequence of the gene associated with x-linked kallmann syndrome, corresponding peptide sequences, diagnostic applications |
| 06/22/1994 | EP0602178A1 T cell receptor-based therapy for rheumatoid arthritis |
| 06/22/1994 | EP0602144A1 Dna sequences encoding gelonin polypeptide |
| 06/22/1994 | EP0602126A1 Immunoglobulin variants for specific fc epsilon receptors |
| 06/22/1994 | EP0602098A1 Biocidal proteins |
| 06/22/1994 | EP0602079A1 POLYPEPTIDES CAPABLE OF $i(IN VIVO) INDUCTION OF ANTIBODIES THEMSELVES CAPABLE OF INHIBITING THE INVASION OF RED BLOOD CORPUSCLES BY MEROZOITES OF $i(P.FALCIPARUM), RELATED PRODUCTS AND THEIR USE IN PRODUCING VACCINE COMPOSITIONS |
| 06/22/1994 | EP0602046A1 Detection of feline immunodeficiency viruses |
| 06/22/1994 | EP0602044A1 A cDNA CLONE ENCODING A HUMAN NOREPINEPRHINE TRANSPORTER |
| 06/22/1994 | EP0547064B1 Protease resistant pdgf and methods of use |
| 06/22/1994 | EP0530260B1 Production of a proteinaceous composition |
| 06/22/1994 | EP0497757B1 E. coli secretory strains |
| 06/22/1994 | EP0486525B1 Stabilized protein or peptide conjugates |
| 06/22/1994 | EP0418219B1 cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS |
| 06/22/1994 | EP0413024B1 Protein having activity of inhibiting inflammation-inducing phospholipase a2 |
| 06/22/1994 | EP0302887B1 Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| 06/22/1994 | EP0177568B1 Recombinant dna molecules |
| 06/22/1994 | EP0176588B1 Platelet related growth regulator |
| 06/22/1994 | CN1088217A Vaccines |
| 06/22/1994 | CN1088216A Modified platelet factor-4 |
| 06/22/1994 | CN1025118C Method for prepairing cell growth hormone |
| 06/21/1994 | US5322936 Nucleic acids encoding trypanosoma cruzi heparin-binding protein |
| 06/21/1994 | US5322930 Fusion protein containing carrier protein with peptide fused to cleavage site; high isoelectric point facilitates separation |
| 06/21/1994 | US5322801 Protein partner screening assays and uses thereof |
| 06/21/1994 | US5322788 Monoclonal anti-body to cell surface protein of the bacterium Streptococcus pneumoniae |
| 06/21/1994 | US5322777 Administering for bacterial infections; obtained from culture of Planobispora rosea ATCC 53773 |
| 06/21/1994 | US5322774 Procaryotic leader sequence in recombinant baculovirus expression system |
| 06/21/1994 | US5322773 Using protease |
| 06/21/1994 | US5322769 Methods for using CKS fusion proteins |